172 related articles for article (PubMed ID: 26582178)
1. The performance of NLST screening criteria in Asian lung cancer patients.
Kumar V; Becker K; Zheng HX; Huang Y; Xu Y
BMC Cancer; 2015 Nov; 15():916. PubMed ID: 26582178
[TBL] [Abstract][Full Text] [Related]
2. Assessment of Selection Criteria for Low-Dose Lung Screening CT Among Asian Ethnic Groups in Taiwan: From Mass Screening to Specific Risk-Based Screening for Non-Smoker Lung Cancer.
Wu FZ; Huang YL; Wu CC; Tang EK; Chen CS; Mar GY; Yen Y; Wu MT
Clin Lung Cancer; 2016 Sep; 17(5):e45-e56. PubMed ID: 27133540
[TBL] [Abstract][Full Text] [Related]
3. Improving selection criteria for lung cancer screening. The potential role of emphysema.
Sanchez-Salcedo P; Wilson DO; de-Torres JP; Weissfeld JL; Berto J; Campo A; Alcaide AB; Pueyo J; Bastarrika G; Seijo LM; Pajares MJ; Pio R; Montuenga LM; Zulueta JJ
Am J Respir Crit Care Med; 2015 Apr; 191(8):924-31. PubMed ID: 25668622
[TBL] [Abstract][Full Text] [Related]
4. Applying the National Lung Screening Trial eligibility criteria to the US population: what percent of the population and of incident lung cancers would be covered?
Pinsky PF; Berg CD
J Med Screen; 2012 Sep; 19(3):154-6. PubMed ID: 23060474
[TBL] [Abstract][Full Text] [Related]
5. Cost-Effectiveness Analysis of Lung Cancer Screening in the United States: A Comparative Modeling Study.
Criss SD; Cao P; Bastani M; Ten Haaf K; Chen Y; Sheehan DF; Blom EF; Toumazis I; Jeon J; de Koning HJ; Plevritis SK; Meza R; Kong CY
Ann Intern Med; 2019 Dec; 171(11):796-804. PubMed ID: 31683314
[TBL] [Abstract][Full Text] [Related]
6. Characteristics and Outcomes of Lung Cancers Detected on Low-Dose Lung Cancer Screening CT.
Zhang EW; Shepard JO; Kuo A; Chintanapakdee W; Keane F; Gainor JF; Mino-Kenudson M; Lanuti M; Lennes IT; Digumarthy SR
Cancer Epidemiol Biomarkers Prev; 2021 Aug; 30(8):1472-1479. PubMed ID: 34108138
[TBL] [Abstract][Full Text] [Related]
7. Baseline characteristics of participants in the randomized national lung screening trial.
; Aberle DR; Adams AM; Berg CD; Clapp JD; Clingan KL; Gareen IF; Lynch DA; Marcus PM; Pinsky PF
J Natl Cancer Inst; 2010 Dec; 102(23):1771-9. PubMed ID: 21119104
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of Singapore lung cancer patients who miss out on lung cancer screening recommendations.
Loh CH; Koh PW; Ang DJM; Lee WC; Chew WM; Koh JMK
Singapore Med J; 2024 May; 65(5):279-287. PubMed ID: 35366661
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of 5 lung cancer natural history and screening models that reproduce outcomes of the NLST and PLCO trials.
Meza R; ten Haaf K; Kong CY; Erdogan A; Black WC; Tammemagi MC; Choi SE; Jeon J; Han SS; Munshi V; van Rosmalen J; Pinsky P; McMahon PM; de Koning HJ; Feuer EJ; Hazelton WD; Plevritis SK
Cancer; 2014 Jun; 120(11):1713-24. PubMed ID: 24577803
[TBL] [Abstract][Full Text] [Related]
10. Adherence to general medical checkup and cancer screening guidelines according to self-reported smoking status: Korea National Health and Nutrition Examination Survey (KNHANES) 2010-2012.
Kim EY; Shim YS; Kim YS; Lee SP; Ko KD; Choi WJ
PLoS One; 2019; 14(10):e0224224. PubMed ID: 31639166
[TBL] [Abstract][Full Text] [Related]
11. Identifying high-risk individuals for lung cancer screening: Going beyond NLST criteria.
Fu M; Travier N; Martín-Sánchez JC; Martínez-Sánchez JM; Vidal C; Garcia M;
PLoS One; 2018; 13(4):e0195441. PubMed ID: 29621354
[TBL] [Abstract][Full Text] [Related]
12. Assessing the Generalizability of the National Lung Screening Trial: Comparison of Patients with Stage 1 Disease.
Tanner NT; Dai L; Bade BC; Gebregziabher M; Silvestri GA
Am J Respir Crit Care Med; 2017 Sep; 196(5):602-608. PubMed ID: 28722466
[TBL] [Abstract][Full Text] [Related]
13. Comorbidities, smoking status, and life expectancy among individuals eligible for lung cancer screening.
Howard DH; Richards TB; Bach PB; Kegler MC; Berg CJ
Cancer; 2015 Dec; 121(24):4341-7. PubMed ID: 26372542
[TBL] [Abstract][Full Text] [Related]
14. Utility of the National Lung Screening Trial Criteria for Estimation of Lung Cancer in the Korean Population.
Lee YJ; Choi SM; Lee J; Lee CH; Lee SM; Yoo CG; Kim YW; Han SK; Park YS
Cancer Res Treat; 2018 Jul; 50(3):950-955. PubMed ID: 29025257
[TBL] [Abstract][Full Text] [Related]
15. 'Reduced' HUNT model outperforms NLST and NELSON study criteria in predicting lung cancer in the Danish screening trial.
Røe OD; Markaki M; Tsamardinos I; Lagani V; Nguyen OTD; Pedersen JH; Saghir Z; Ashraf HG
BMJ Open Respir Res; 2019; 6(1):e000512. PubMed ID: 31803478
[TBL] [Abstract][Full Text] [Related]
16. Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment.
Pinsky PF; Gierada DS; Black W; Munden R; Nath H; Aberle D; Kazerooni E
Ann Intern Med; 2015 Apr; 162(7):485-91. PubMed ID: 25664444
[TBL] [Abstract][Full Text] [Related]
17. Role of Low-Dose Computerized Tomography in Lung Cancer Screening among Never-Smokers.
Kang HR; Cho JY; Lee SH; Lee YJ; Park JS; Cho YJ; Yoon HI; Lee KW; Lee JH; Lee CT
J Thorac Oncol; 2019 Mar; 14(3):436-444. PubMed ID: 30445189
[TBL] [Abstract][Full Text] [Related]
18. Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening.
Katki HA; Kovalchik SA; Berg CD; Cheung LC; Chaturvedi AK
JAMA; 2016 Jun; 315(21):2300-11. PubMed ID: 27179989
[TBL] [Abstract][Full Text] [Related]
19. Proportion of Non-Small-Cell Lung Cancer Patients that Would Have Been Eligible for Lung Cancer Screening.
Wu GX; Goldstein L; Kim JY; Raz DJ
Clin Lung Cancer; 2016 Sep; 17(5):e131-e139. PubMed ID: 26872765
[TBL] [Abstract][Full Text] [Related]
20. Comparing Lung Cancer Screening Strategies in a Nationally Representative US Population Using Transportability Methods for the National Lung Cancer Screening Trial.
Robertson SE; Joyce NR; Steingrimsson JA; Stuart EA; Aberle DR; Gatsonis CA; Dahabreh IJ
JAMA Netw Open; 2024 Jan; 7(1):e2346295. PubMed ID: 38289605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
